Mesenchymal stem cells derived from adipose tissue for intra-lymphatic administration in autoimmune and inflammatory diseases

摘要

A stem cell, regulatory T cell and / or fibroblast, for use in a method of: (i) treating or repairing damaged tissue; and / or (ii) treat, modulate, improve and / or prophylaxis of one or more symptoms associated with inflammatory and / or immune disorders; wherein the cell is administered to the lymphatic system in a dose schedule comprising the administration of a dose, or multiple doses separated by at least 12 hours, wherein the or each dose comprises between 100,000 and 100 million cells.